OVERVIEW - SYNCOM FORMULATIONS (INDIA) LIMITED

Syncom Formulations (India) Limited is a listed public company incorporated on 21 June, 1988. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 95.00 cr and the total paid-up capital is INR 94.00 cr.

Syncom Formulations (India) Limited's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by -45.83 % over the previous year. At the same time, it's book networth has increased by 18.47 %. Other performance and liquidity ratios are available here.

Description: The company is engaged in pharmaceutical formulation products such as tablets, capsules, liquids orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments, inhalers and herbals.

Products & Services: Tablets, capsules, liquids orals, liquid vials and ampoule injections
Category: Service Provider

The current status of Syncom Formulations (India) Limited is - Active.

The last reported AGM (Annual General Meeting) of Syncom Formulations (India) Limited, per our records, was held on 26 September, 2023.

Syncom Formulations (India) Limited has nine directors - Vijay Shankarlal Bankda, Kedarmal Shankarlal Bankda, and others.

The Corporate Identification Number (CIN) of Syncom Formulations (India) Limited is L24239MH1988PLC047759. The registered office of Syncom Formulations (India) Limited is at 7, Niraj Industrial Estate, Off Mahakali Caves Road Andher i (East) NA, Mumbai, Mumbai City, Maharashtra.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - SYNCOM FORMULATIONS (INDIA) LIMITED


CIN

L24239MH1988PLC047759

Incorporation Date / Age

21 June, 1988 / 36 yrs

Last Reported AGM Date

26 September, 2023


Authorized Capital

INR 9500.0 Lacs

Paidup Capital

INR 9400.0 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Listed Public Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

http://www.syncomformulations.com. (Incorrect website?)

Registered Address

7, Niraj Industrial Estate, Off Mahakali Caves Road Andher
i (East) NA
Mumbai
Mumbai City - 400093
Maharashtra - India


How to download SYNCOM FORMULATIONS (INDIA) LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

SYNCOM FORMULATIONS (INDIA) LIMITED - Registration Details
CINL24239MH1988PLC047759
Incorporation Date / Age21 June, 1988 / 36 yrs
Last Reported AGM Date26 September, 2023
Authorized CapitalINR 9500.0 Lacs
Paidup CapitalINR 9400.0 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeListed Public Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://www.syncomformulations.com
Registered Address7, Niraj Industrial Estate, Off Mahakali Caves Road Andher i (East) NA Mumbai Mumbai City - 400093 Maharashtra - India

FINANCIAL HIGHLIGHTS - SYNCOM FORMULATIONS (INDIA) LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2022. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue INR 100 cr - 500 cr
EBITDA -45.83 %
Networth 18.47 %
Debt/Equity Ratio 0.26
Return on Equity 8.91 %

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of SYNCOM FORMULATIONS (INDIA) LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - SYNCOM FORMULATIONS (INDIA) LIMITED

The company has 9 directors and 2 reported key management personnel.


The longest serving director currently on board is Kedarmal Shankarlal Bankda who was appointed on 13 April, 1992. Kedarmal Shankarlal Bankda has been on the board for more than 32 years. The most recently appointed directors are Ankit Jain and Ritesh Kumar Lunkad, who were appointed on 14 August, 2023.


Kedarmal Shankarlal Bankda has the largest number of other directorships with a seat at a total of 5 companies. In total, the company is connected to 7 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
VIJAY SHANKARLAL BANKDA Director 01 December, 1999 Other directorships - SANTE BIOTECH PRIVATE LIMITED,  SYNMEX PHARMA PRIVATE LIMITED,  VINCIT BIOTECH INTERNATIONAL PRIVATE LIMITED, 
KEDARMAL SHANKARLAL BANKDA Director 13 April, 1992 Other directorships - SANTE BIOTECH PRIVATE LIMITED,  SYNMEX PHARMA PRIVATE LIMITED,  ARP PHARMA PRIVATE LIMITED,  VINCIT BIOTECH INTERNATIONAL PRIVATE LIMITED, 
VINOD KUMAR KABRA Director 29 September, 2007 No other directorships
KRISHNA DAS NEEMA Director 31 July, 2008 No other directorships
ANKIT KEDARMAL BANKDA KMP 01 April, 2014 No other directorships
PRAVEEN JINDAL Director 12 July, 2012 Other directorships - FLOWWORKS CONSULTING PRIVATE LIMITED,  UPVENTURES PRIVATE LIMITED, 
ANKIT JAIN Director 14 August, 2023 Other directorships - IRONMAN STEELS PRIVATE LIMITED, 
RINKI ANKIT BANKDA Director 13 August, 2014 No other directorships
RUCHI JINDAL Director 28 June, 2022 No other directorships
RITESH KUMAR LUNKAD Director 14 August, 2023 No other directorships
VAISHALI AGRAWAL KMP 03 May, 2023 No other directorships
NAME DESIGNATION APPOINTMENT DATE
VIJAY SHANKARLAL BANKDA Director 01 December, 1999 View other directorships
KEDARMAL SHANKARLAL BANKDA Director 13 April, 1992 View other directorships
VINOD KUMAR KABRA Director 29 September, 2007 No other directorships
KRISHNA DAS NEEMA Director 31 July, 2008 No other directorships
ANKIT KEDARMAL BANKDA KMP 01 April, 2014 No other directorships
PRAVEEN JINDAL Director 12 July, 2012 View other directorships
ANKIT JAIN Director 14 August, 2023 View other directorships
RINKI ANKIT BANKDA Director 13 August, 2014 No other directorships
RUCHI JINDAL Director 28 June, 2022 No other directorships
RITESH KUMAR LUNKAD Director 14 August, 2023 No other directorships
VAISHALI AGRAWAL KMP 03 May, 2023 No other directorships
13 April, 1992
01 December, 1999
29 September, 2007
31 July, 2008
12 July, 2012

PRAVEEN JINDAL

Director

01 April, 2014

ANKIT KEDARMAL BANKDA

KMP

13 August, 2014
28 June, 2022

RUCHI JINDAL

Director

03 May, 2023

VAISHALI AGRAWAL

KMP

14 August, 2023

ANKIT JAIN

Director

14 August, 2023

Bank-wise Biggest Charges on Assets

See more...

Previous Names

No previous names were found for this company.

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
PRECISION CAMSHAFTS LIMITED It was formed in year 1992 in Maharashtra . The company currently has a paid up capital of INR 94.99 cr.
1992 Maharashtra 94.99 cr Buy financial reports
INDUS GENE EXPRESSIONS LIMITED It was formed in year 2007 in Andhra Pradesh . The company currently has a paid up capital of INR 92.83 cr.
2007 Andhra Pradesh 92.83 cr Buy financial reports
ASIAN PAINTS LIMITED It was formed in year 1945 in Maharashtra . The company currently has a paid up capital of INR 95.92 cr.
1945 Maharashtra 95.92 cr Buy financial reports
SMILAX LABORATORIES LIMITED It was formed in year 2004 in Telangana . The company currently has a paid up capital of INR 96.04 cr.
2004 Telangana 96.04 cr Buy financial reports
STRIDES PHARMA SCIENCE LIMITED It was formed in year 1990 in Maharashtra . The company currently has a paid up capital of INR 91.90 cr.
1990 Maharashtra 91.90 cr Buy financial reports
LYRUS LIFE SCIENCES PRIVATE LIMITED It was formed in year 2015 in Karnataka . The company currently has a paid up capital of INR 96.23 cr.
2015 Karnataka 96.23 cr Buy financial reports
INDRAPRASTHA MEDICAL CORPORATION LIMITED It was formed in year 1988 in Delhi . The company currently has a paid up capital of INR 91.67 cr.
1988 Delhi 91.67 cr Buy financial reports
USV PRIVATE LIMITED It was formed in year 1961 in Maharashtra . The company currently has a paid up capital of INR 91.59 cr.
1961 Maharashtra 91.59 cr Buy financial reports
HIL (INDIA) LIMITED It was formed in year 1954 in Delhi . The company currently has a paid up capital of INR 91.33 cr.
1954 Delhi 91.33 cr Buy financial reports
GAMA COLOURS LIMITED It was formed in year 1988 in Gujarat . The company currently has a paid up capital of INR 91.00 cr.
1988 Gujarat 91.00 cr Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - SYNCOM FORMULATIONS (INDIA) LIMITED

Company Network • Tofler Business Research Platform
How to use company network of SYNCOM FORMULATIONS (INDIA) LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - SYNCOM FORMULATIONS (INDIA) LIMITED

  • What is the Incorporation date of SYNCOM FORMULATIONS (INDIA) LIMITED?

    The Incorporation Date of SYNCOM FORMULATIONS (INDIA) LIMITED is 21 June, 1988.

  • What is the operating revenue of SYNCOM FORMULATIONS (INDIA) LIMITED?

    The operating revenue of SYNCOM FORMULATIONS (INDIA) LIMITED is in the range of INR 100 cr - 500 cr for the financial year ending on 31 March, 2022.

  • What is the change in EBITDA of SYNCOM FORMULATIONS (INDIA) LIMITED since last year?

    The EBITDA of SYNCOM FORMULATIONS (INDIA) LIMITED has decreased by -45.83 % over the previous year. At the same time, it's book networth has increased by 18.47 % for the financial year ending 31 March, 2022.

  • What is the business of SYNCOM FORMULATIONS (INDIA) LIMITED?

    The company is engaged in pharmaceutical formulation products such as tablets, capsules, liquids orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments, inhalers and herbals..

  • Which Products and Services are provided by SYNCOM FORMULATIONS (INDIA) LIMITED?

    The products and services offered by SYNCOM FORMULATIONS (INDIA) LIMITED are Tablets, capsules, liquids orals, liquid vials and ampoule injections.

  • Who are the directors of SYNCOM FORMULATIONS (INDIA) LIMITED?

    Syncom Formulations (India) Limited has nine directors - Vijay Shankarlal Bankda, Kedarmal Shankarlal Bankda, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More